Company / Cost of Revenue
CANNABIS SUISSE CORP. Cost of Revenue History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$22.1K
FY2024
5-year range
$1.7K / $102.6K
FY2020-FY2024
Trend
-26.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has fluctuated over the past 6 years, ranging from $1,734 in FY2022 to $327,526 in FY2019.
Based on SEC 10-K filings.
$22,068 in FY2024 with a 5-year CAGR of -41.7%.
Increased from $1,734 to $22,068 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -40.1%
- 5-Year CAGR
- -41.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -41.7%, indicating a declining trend.
- In FY2024, cost of revenue decreased 26.6% year-over-year.
- Peak cost of revenue was recorded in FY2019.
- Lowest cost of revenue in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -4.63 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $22.1K | -26.6% |
| FY2023 | $30.1K | +1634.0% |
| FY2022 | $1.7K | -98.3% |
| FY2021 | $102.6K | -68.7% |
| FY2019 | $327.5K | - |
| FY2018 | - | - |
| FY2017 | $2.3K | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026